Skip to main content

Table 5 HPLC results for Partner medicines (PM)

From: Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use

Partner Medicines Below 85 % Within 85–115 % Above 115 % Total N = 254
Amodiaquinea
n (%)
28 (25.2) 64 (57.7) 19 (17.1) 111 (100.0)
Median (IQR) 80.6 (72.6–82.9) 92.7 (88.3–97.2) 118.8 (117.2–121.4) 92.0 (84.9–101.7)
Lumefantrineb
n (%)
4 (3.0) 120 (89.6) 10 (7.5) 134 (100.0)
Median (IQR) 83.3 (77.4–84.4) 99.4 (93.2–105.0) 117.6 (116.2–118.5) 100.3 (93.1–107.1)
Piperaquinec
n (%)
0 (0.0) 3 (33.3) 6 (66.7) 9 (100.0)
Median (IQR) 0 112.1 (111.5–114.7) 121.1 (117.5–123.8) 117.5 (114.7–121.7)
Combined
n (%)
32 (12.6) 187 (73.6) 35 (13.8) 254 (100.0)
Median (IQR) 81.4 (72.8–83.0) 96.6 (91.6–103.4) 118.7 (117.2–120.7) 96.8 (88.9–108.4)
  1. Note: a, b, cwere derived from Artesunate Amodiaquine. Artemether Lumefantrine and Dihydroartemisinin Piperaquine respectively